ALKBH1 and hepatocellular carcinoma: Similar results were observed in the study of HCC, where the overexpression of N6AMT1, a methyltransferase, increased N6mA levels, resulting in enhanced cell viability, reduced apoptosis, and increased cell migration and invasion, whereas the overexpression of ALKBH1 had the opposite effect [43].